Using these inhibitors, we show for the first time a potential role for the FAD and LSD1-CoREST complex in mediating downstream gene signatures to generate an M1-like macrophage phenotype in vitro and in the TME of mouse triple-negative breast cancers. The gene discussed is RCOR1; the disease is triple-negative breast carcinoma.